IVF Reads / Should You Take Folate or B12 to Conceive?

Should You Take Folate or B12 to Conceive?

M
Written by MayaPublished Updated
AI summary

Periconceptional folic acid prevents neural tube defects: Cochrane 2015 found a risk ratio of 0.31 (95% CI 0.17 to 0.58) across 5 trials and 6,708 births, rated high-quality evidence. It is not a fertility treatment. In FAZST (JAMA 2020), 2,370 couples, folic acid plus zinc taken by the male partner gave live birth in 34% versus 35% on placebo, and no improvement in any semen parameter.

  • Cochrane 2015 (PMID 26662928): daily folic acid before and around conception reduced neural tube defects, risk ratio 0.31 (95% CI 0.17 to 0.58), 5 trials, 6,708 births, high-quality evidence.
  • FAZST (JAMA 2020, PMID 31910279): in 2,370 couples, folic acid plus zinc given to the male partner for 6 months produced live birth in 404 of 1,185 (34%) versus 416 of 1,185 (35%) on placebo, risk difference -0.9% (95% CI -4.7% to 2.8%).
  • FAZST also found sperm DNA fragmentation higher on the supplement, 29.7% versus 27.2% on placebo (mean difference 2.4%, 95% CI 0.5% to 4.4%).
  • SUMMER (JAMA Netw Open 2025, PMID 40996763): 1,171 men took a supplement containing folic acid and vitamin B12; ongoing pregnancy was 33.8% versus 37.5% on placebo (adjusted odds ratio 0.85, 95% CI 0.66 to 1.09).
  • NICE NG257 recommendation 1.24.6 [2026]: "Do not offer supplements, antioxidants or medical treatments to improve sperm DNA integrity (fragmentation)."
  • No randomised trial of vitamin B12 on its own, measuring semen quality or live birth, was found in a PubMed search on 30 September 2026.

Should you take folate or B12 to conceive?

If you could become pregnant, take folic acid — but take it for the baby, not to conceive faster. It prevents a serious birth defect in a pregnancy you go on to have. It has not been shown to help you get pregnant.

If you are the male partner and you bought it to improve a semen result, the honest answer is that it has been tested and it did not work. Two large randomised trials, one of 2,370 couples and one of 1,171 men, found no improvement in semen quality and no more pregnancies.

Vitamin B12 is the weaker half of the question. It has never been tested on its own for fertility outcomes at all.

Live birth, folic acid and zinc versus placebo in men34% vs 35%404 of 1,185 couples versus 416 of 1,185; risk difference -0.9% (95% CI -4.7% to 2.8%). No significant difference.FAZST randomised clinical trial, Schisterman et al., JAMA 2020;323(1):35-48, PMID 31910279. Correction: JAMA 2020;323(12):1194 (PMID 32207776), two rows transposed in the baseline table; outcomes unaffected.

What did the largest trial of folate for men actually find?

The Folic Acid and Zinc Supplementation Trial (FAZST) enrolled 2,370 couples at four American fertility centres between 2013 and 2017. The male partner took either folic acid with elemental zinc, or an identical placebo, every day for six months. It was designed to settle exactly the question you are holding a bottle about.

Nothing improved. Sperm concentration, motility, morphology, volume and total motile count were all not significantly different at six months. Live birth was not different either. Two things did change, and both went the wrong way: sperm DNA fragmentation was higher on the supplement, and stomach upset was more common — abdominal discomfort or pain in 66 men (6%) on the supplement versus 40 (3%) on placebo, with nausea and vomiting also more frequent.

The trial carries a published correction (JAMA 2020;323(12):1194). Two rows were transposed in the baseline characteristics table. The results above are unaffected.

The trial authors' own conclusion: these findings "do not support the use of folic acid and zinc supplementation by male partners in the treatment of infertility".

Sperm DNA fragmentation after 6 months29.7% vs 27.2%Higher on folic acid and zinc than on placebo; mean difference 2.4% (95% CI 0.5% to 4.4%), among 1,629 men with semen available for analysis.FAZST, JAMA 2020;323(1):35-48, PMID 31910279.

Does adding B12 change the answer?

This is the closest anyone has come to testing it. The SUMMER trial, published in 2025, randomised 1,171 men across 21 Dutch hospitals and fertility clinics to a daily supplement or an identical placebo for six months. The supplement contained folic acid and vitamin B12 together with zinc, betaine, cystine, niacin, vitamin B6 and vitamin B2 — much the same mixture sold as a men's fertility multivitamin.

Ongoing pregnancy within six months was 33.8% on the supplement versus 37.5% on placebo, a difference that was not statistically significant. In the four-to-six-month window the investigators call the window of optimal treatment effect, because that is when a full cycle of sperm production would have been exposed to the supplement, the supplement group did worse: ongoing pregnancy 15.5% versus 21.5%. No secondary outcome, including semen parameters and DNA fragmentation, differed between the groups.

Two limits matter when you read that. It tested a combination, so nothing in it can be pinned on B12 specifically. And a single significant result inside a subgroup window is not proof that a supplement causes harm — the main result is simply that it did not help.

As for B12 alone: a PubMed search on 30 September 2026 found no randomised trial testing vitamin B12 by itself against semen quality or live birth. Not a negative trial — no trial. Anything you read asserting that B12 raises sperm count is not resting on one.

Ongoing pregnancy, folic-acid-and-B12 supplement versus placebo33.8% vs 37.5%193 of 571 men versus 208 of 555; adjusted odds ratio 0.85 (95% CI 0.66 to 1.09), P = 0.20. Not significant.SUMMER randomised clinical trial, de Ligny et al., JAMA Network Open 2025;8(9):e2532405, PMID 40996763.

Why folic acid before pregnancy is still worth taking

None of the above touches the one folate claim that is settled. A Cochrane review of five randomised trials covering 6,708 births found that daily folic acid before and around conception reduced neural tube defects — spina bifida and anencephaly — with a risk ratio of 0.31 (95% CI 0.17 to 0.58). Cochrane rated that high-quality evidence, its top grade. Among women who had already had an affected pregnancy, the reduction in recurrence was similar, risk ratio 0.34 (95% CI 0.18 to 0.64) across 4 randomised trials and 1,846 births.

NICE's maternal and child nutrition guideline (NG247, 2025) puts the timing plainly in recommendation 1.1.3: folic acid should be started before trying for a baby, ideally three months before, or as early as possible after a positive test, and continued for at least the first 12 weeks of pregnancy. It also says to keep taking the supplement even where flour and other food is fortified.

Read the outcome that review measured, because it is the whole distinction on this page. It counted birth defects in babies who were conceived. It did not count how many women conceived. The same review found no clear effect on cleft lip, cleft palate, congenital heart defects, or miscarriage.

Neural tube defects with periconceptional folic acidRR 0.3195% CI 0.17 to 0.58, across 5 randomised trials and 6,708 births. Graded high-quality evidence.De-Regil LM et al., Cochrane Database of Systematic Reviews 2015;(12):CD007950, PMID 26662928.

Want your own results explained?

IVY can read your reports alongside your history and set out what the evidence supports for your situation — and what it does not.

My doctor prescribed this — should I stop?

Do not stop a prescription because of a web page, including this one. Ask which of three different reasons it was given for, because the evidence above only speaks to one of them.

  • To prevent neural tube defects, for someone who could become pregnant. Keep taking it. This is the use the Cochrane evidence supports and NG247 recommends.
  • To correct a measured deficiency — a low folate or low B12 blood result, pernicious anaemia, coeliac disease, or after bariatric surgery. That is treatment for the deficiency, and it has its own reasons that have nothing to do with the trials on this page.
  • To improve a semen result. This is the use FAZST and SUMMER tested and did not support, and the use NICE NG257 recommendation 1.24.6 [2026] advises against: "Do not offer supplements, antioxidants or medical treatments to improve sperm DNA integrity (fragmentation)."

If it is the third reason, a fair question to your doctor is what result is expected to change and when it will be checked. A supplement with no review date is hard to stop.

What to do instead if the semen analysis came back abnormal

One abnormal semen analysis is not a diagnosis. NICE NG257 recommendation 1.17.3 says to offer a repeat confirmatory test when the first result is abnormal, and 1.17.4 sets the interval: "Undertake repeat confirmatory tests ideally 3 months after the initial analysis to allow time for the cycle of spermatozoa formation to be completed."

Three months is not arbitrary. When researchers labelled sperm DNA directly with a stable isotope in 11 men with normal sperm concentrations, labelled sperm first appeared in the ejaculate after 64 days on average, give or take 8, ranging from 42 to 76 days. Anything you change today shows up in a result taken about three months later, whether that is a supplement, an illness, a fever or stopping smoking.

Two more things worth knowing before you spend money. NG257 1.17.6 says not to carry out testing for sperm DNA integrity (fragmentation) at all — so a fragmentation test sold alongside a supplement is measuring something the guideline does not ask for. And if the real question is whether you are actually deficient, the answer comes from measuring folate or B12 in blood, not from taking a supplement and hoping.

Related: whether foods or supplements actually improve sperm quality, zinc and sperm health, and what the male fertility supplement evidence adds up to.

What the evidence does not establish

Several things on this page are genuinely unsettled, and a few common claims are weaker than they look.

  • That antioxidant supplements improve live birth in men. The 2022 Cochrane review of 90 studies found an odds ratio of 1.43 (95% CI 1.07 to 1.91) for live birth across 12 randomised trials and 1,283 men — but rated it very low certainty, and when the trials at high risk of bias were removed the signal disappeared: Peto odds ratio 1.22 (95% CI 0.85 to 1.75) across 8 randomised trials and 827 men. The benefit rests on the weakest studies.
  • That vitamin B12 does anything for fertility. There is no randomised trial of B12 alone with a fertility outcome to cite, in either direction.
  • That folic acid is useless for every man. FAZST tested one dose pairing, for six months, in couples already seeking fertility treatment. It does not tell you what happens in a man with a documented folate deficiency, which no trial has addressed separately.
  • That the higher DNA fragmentation in FAZST harmed anyone. The difference was small, live birth did not fall, and NG257 1.17.6 does not recommend measuring fragmentation in the first place.
  • That folic acid prevents miscarriage. The Cochrane review looked: risk ratio 1.10 (95% CI 0.94 to 1.28) across 5 trials and 7,391 pregnancies, moderate-quality evidence. No effect either way.
  • That any of this is a substitute for finding the cause. Sometimes the answer is testing, timing, or a simpler treatment than IVF — and sometimes IVF is not indicated at all.

It is worth saying the obvious thing about why supplements are so hard to put down. When you are waiting, a bottle is often the only part of this that feels like it is in your hands. That is a real feeling, and it is not a reason the evidence changes.

Not sure what your results mean?

Upload your test results and IVY will explain what has been checked, what it shows, and what usually comes next.

Keep reading

7 Sources

  1. Schisterman EF, Sjaarda LA, Clemons T, et al. Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial (FAZST). JAMA. 2020;323(1):35-48. PMID 31910279. Multicentre randomised trial, 2,370 couples at 4 US centres; male partner took 5 mg folic acid plus 30 mg elemental zinc or placebo daily for 6 months. Live birth 404/1,185 (34%) versus 416/1,185 (35%), risk difference -0.9% (95% CI -4.7% to 2.8%). Sperm concentration, motility, morphology, volume and total motile count not significantly different. Sperm DNA fragmentation HIGHER with supplementation, 29.7% versus 27.2% (mean difference 2.4%, 95% CI 0.5% to 4.4%), among 1,629 men with semen analysed. Gastrointestinal symptoms more common (abdominal pain 66 vs 40; nausea 50 vs 24; vomiting 32 vs 17). Authors conclude the findings "do not support the use of folic acid and zinc supplementation by male partners in the treatment of infertility". Published correction: JAMA. 2020;323(12):1194, PMID 32207776, "Two Rows Transposed in Table 1" (baseline characteristics; outcomes unaffected). JAMA
  2. de Ligny WR, de Bruin JP, Smits RM, et al. Antioxidant Treatment and the Chance to Conceive in Men Seeking Fertility Care: The SUMMER Randomized Clinical Trial. JAMA Network Open. 2025;8(9):e2532405. PMID 40996763. Double-blind placebo-controlled trial, 21 Dutch centres, 1,171 men analysed (591 supplement, 580 placebo), enrolled 2018-2024. Daily tablet containing betaine 200 mg, L-cystine 200 mg, niacin 16 mg, zinc 10 mg, vitamin B6 1.4 mg, vitamin B2 1.4 mg, folic acid 400 ug and vitamin B12 2.5 ug, for 6 months. Ongoing pregnancy within 6 months 193/571 (33.8%) versus 208/555 (37.5%), adjusted odds ratio 0.85 (95% CI 0.66 to 1.09), P = 0.20. Within what the authors term "the window of optimal treatment effect between 4 and 6 months (considering a spermatogenesis cycle of 72 days)", ongoing pregnancy was significantly LOWER on the supplement, 69/446 (15.5%) versus 95/442 (21.5%), adjusted odds ratio 0.66 (95% CI 0.47 to 0.94), P = 0.02. No significant differences in secondary outcomes including semen parameters and sperm DNA fragmentation. Investigators do not support its use in men seeking fertility care. JAMA Network Open
  3. De-Regil LM, Pena-Rosas JP, Fernandez-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database of Systematic Reviews. 2015;(12):CD007950. PMID 26662928. Five trials, 7,391 women. Daily folic acid, alone or with other vitamins and minerals, reduced neural tube defects: risk ratio 0.31 (95% CI 0.17 to 0.58), 5 studies, 6,708 births, HIGH quality evidence. Recurrence: risk ratio 0.34 (95% CI 0.18 to 0.64), 4 studies, 1,846 births. No evidence of preventive or negative effect on cleft palate (RR 0.73, 95% CI 0.05 to 10.89), cleft lip (RR 0.79, 95% CI 0.14 to 4.36), congenital cardiovascular defects (RR 0.57, 95% CI 0.24 to 1.33), miscarriage (RR 1.10, 95% CI 0.94 to 1.28; 5 studies, 7,391 pregnancies, moderate quality) or other birth defects. Update of PMID 20927767. Cochrane Database of Systematic Reviews
  4. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257, published 31 March 2026 (replaces CG156, February 2013). Recommendation 1.24.6 [2026]: "Do not offer supplements, antioxidants or medical treatments to improve sperm DNA integrity (fragmentation)." Recommendation 1.17.3: "If the result of the first semen analysis is abnormal, offer a repeat confirmatory test." Recommendation 1.17.4: "Undertake repeat confirmatory tests ideally 3 months after the initial analysis to allow time for the cycle of spermatozoa formation to be completed." Recommendation 1.17.6: "Do not carry out testing for sperm DNA integrity (fragmentation)." National Institute for Health and Care Excellence (NICE)
  5. National Institute for Health and Care Excellence. Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years. NICE guideline NG247, published 15 January 2025. Recommendation 1.1.3 [2025] states that information given about folic acid should cover "What folic acid is and how it helps prevent neural tube defects and other congenital malformations" and "The need to take folic acid before trying for a baby (ideally for 3 months before) or as early as possible after a first positive pregnancy test, and for at least the first 12 weeks of pregnancy", and that supplements should be taken even where food including flour is fortified with folic acid. National Institute for Health and Care Excellence (NICE)
  6. de Ligny W, Smits RM, Mackenzie-Proctor R, et al. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews. 2022;5(5):CD007411. PMID 35506389. Ninety studies, 10,303 subfertile men, 20 different oral antioxidants. Live birth: odds ratio 1.43 (95% CI 1.07 to 1.91), 12 randomised trials, 1,283 men, VERY LOW certainty evidence, based on only 246 live births. When studies at high risk of bias were removed there was no evidence of increased live birth: Peto odds ratio 1.22 (95% CI 0.85 to 1.75), 8 trials, 827 men, P = 0.27. Clinical pregnancy: odds ratio 1.89 (95% CI 1.45 to 2.47), 20 trials, 1,706 men, low certainty. Mild gastrointestinal discomfort more common, odds ratio 2.70 (95% CI 1.46 to 4.99), 16 trials. Authors conclude the current evidence is inconclusive. Update of PMID 30866036. Cochrane Database of Systematic Reviews
  7. Misell LM, Holochwost D, Boban D, et al. A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo. Journal of Urology. 2006;175(1):242-246. PMID 16406920. Eleven men with normal sperm concentrations ingested deuterated water daily for 3 weeks, with semen collected every 2 weeks for up to 90 days. Labelled sperm were detected after a mean of 64 +/- 8 days (range 42 to 76 days), confirming a cycle of spermatogenesis on the shorter side of the traditional 60-to-70-day estimate. Journal of Urology

Frequently asked questions

Common questions on this topic.

Is folate the same thing as folic acid?

Not quite. Folate is the form of vitamin B9 that occurs in food, such as leafy greens and legumes. Folic acid is the manufactured form used in supplements and in fortified flour. Trials and guidelines on preventing neural tube defects, including the Cochrane review and NICE NG247, tested and recommend folic acid specifically, not dietary folate intake.

I am a woman with unexplained infertility. Will folic acid help me conceive?

No trial has shown that. The Cochrane evidence supporting folic acid counted birth defects in babies who were conceived; it was not designed to measure whether more women conceived, and it did not report that. You should still take folic acid if pregnancy is possible, for the reason it is recommended, but it is not a treatment for infertility.

Is the supplement sold in India the same as the one tested in these trials?

Usually not. FAZST tested folic acid paired with elemental zinc at set doses, and SUMMER tested one specific eight-ingredient tablet. Products on sale differ in which ingredients they contain and how much of each, and are not required to match a trial formulation. A trial result applies to what the trial gave, which is worth checking against the label before assuming the evidence transfers.

Should I get tested for MTHFR variants before choosing a folate supplement?

No randomised trial was found showing that choosing a methylated form of folate, or testing for MTHFR variants first, changes any fertility outcome. NICE NG257 recommendation 1.24.6 advises against offering supplements to improve sperm DNA integrity and does not distinguish between forms of folate. If MTHFR testing has been suggested to you, ask what decision the result would change.

Should both partners take the same supplement?

The two situations are not symmetrical, which is why one bottle for the household rarely makes sense. The partner who could become pregnant has a guideline-backed reason to take folic acid around conception. The male partner has two large randomised trials showing no fertility benefit. Anyone with a measured deficiency is a separate case again.

Can you take too much folic acid?

High folic acid intake can mask the blood picture of vitamin B12 deficiency, which is why the two are often considered together. Beyond that, the trials on this page were not designed to measure long-term harm from high intake and cannot answer the question. What they did record is short-term tolerability: in FAZST, gastrointestinal symptoms including abdominal pain, nausea and vomiting were more common on folic acid with zinc than on placebo, among 2,370 randomised couples.